SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 46.25
+3.07 (7.11%)
At close: Jun 29, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 3.65 billion as of June 26, 2026. Its market cap has increased by 50.20% in one year.
Market Cap
3.65B
Enterprise Value
3.08B
Revenue
860.07M
Ranking
n/a
PE Ratio
31.92
Stock Price
46.25
Market Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 3.65B, a decrease of -18.41%. That is a compound annual growth rate of -4.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 3.65B | -11.13% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.24B |
| Shanghai Runda Medical Technology | 5.51B |
| Maccura Biotechnology Co.Ltd | 4.90B |
| Cowealth Medical China | 4.30B |
| Shanghai Labway Clinical Laboratory | 3.21B |
| Thalys Medical Technology Group | 3.08B |
| Medicalsystem Biotechnology | 3.08B |
| Guangdong Hybribio Biotech | 3.06B |